Cation Exchange Polymers for Protein Aggregate Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for removing protein aggregates from biopharmaceutical preparations, such as those containing therapeutic proteins or antibodies, face challenges due to similarities in physical and chemical properties with the product of interest, leading to inefficient separation, especially for lower order aggregates like dimers, trimers, and tetramers, and often require costly and low-capacity chromatography resins.
Innovation Solution
A flow-through chromatography method using a solid support with a controlled density of cation exchange binding groups, specifically between 1 to 30 mM, which selectively binds protein aggregates relative to monomeric proteins, allowing for their separation while maintaining high yield and purity of the product of interest.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional chromatography methods (size exclusion, ion exchange, hydrophobic interaction) are used to remove protein aggregates, then aggregates can be removed from biopharmaceutical preparations, but the separation is inefficient due to similarities in physical and chemical properties between aggregates and monomeric products
Solution Approach 1:
The patent changes the density parameter of cation exchange binding groups on the solid support to a specific range (1-30 mM), which optimizes the electrostatic interaction between the support and protein aggregates. This parameter change enables selective binding of aggregates while allowing monomeric products to pass through, resolving the contradiction between separation efficiency and product purity.
2Quantity of substance
If bind and elute cation exchange chromatography is used, then aggregate removal can be achieved, but an unfavorable trade-off exists between monomer yield and aggregate removal capacity
Solution Approach 1:
The patent extracts only the problematic protein aggregates from the biopharmaceutical preparation by selective binding to the modified solid support, while the monomeric product of interest passes through unchanged. This extraction approach eliminates the need for bind-elute cycles that cause monomer loss, simultaneously achieving high aggregate removal capacity and maintaining high monomer yield.
3Reliability
If ceramic hydroxyapatite chromatography resin is used for aggregate removal, then some aggregate removal success is achieved, but the resin is expensive and exhibits low binding capacity for protein aggregates
Solution Approach 1:
The patent creates a composite solid support by modifying an existing support material with cation exchange binding groups at controlled densities. This composite approach combines the structural benefits of the base support with the selective binding properties of cation exchange groups, achieving both high binding capacity for aggregates and cost-effectiveness compared to specialized ceramic hydroxyapatite resins.
4Ease of operation
If HIC-based flow-through separation is used, then aggregate binding can be achieved, but the method has narrow applicability due to difficult process development, narrow operating window, and high salt concentration requirements
Solution Approach 1:
The patent replaces the hydrophobic interaction mechanism of HIC with electrostatic interactions via cation exchange binding groups. This substitution eliminates the need for high salt concentrations and narrow operating windows, creating a more versatile method that works under broader pH and ionic strength conditions while maintaining ease of flow-through operation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces protein aggregate concentration by at least 50% in the effluent, achieving greater than 80% recovery of the monomeric protein with improved selectivity and capacity compared to existing methods, eliminating the need for salt addition and subsequent dilution steps, and can be integrated into continuous purification processes.
Implementation Method 1
contacting the sample with a solid support comprising one or more cation exchange binding groups attached thereto, at a density of about 1 to about 30 mM, where the solid support selectively binds protein aggregates
Data Source
Figure 1~2B
Figure 2C~2E
Figure 2F~2H
AI summary
The present invention provides novel compositions and methods for removal of protein aggregates from a sample in a flow-through mode.